Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 703,054 shares of the medical equipment provider’s stock after purchasing an additional 6,465 shares during the quarter. Intuitive Surgical makes up 0.6% of DekaBank Deutsche Girozentrale’s holdings, making the stock its 27th biggest position. DekaBank Deutsche Girozentrale owned about 0.20% of Intuitive Surgical worth $336,944,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Ullmann Wealth Partners Group LLC increased its position in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after acquiring an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC increased its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after purchasing an additional 23 shares during the period. Daymark Wealth Partners LLC increased its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after purchasing an additional 24 shares during the period. Indiana Trust & Investment Management CO raised its position in Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 25 shares in the last quarter. Finally, Hoxton Planning & Management LLC boosted its stake in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after buying an additional 25 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $511.27 on Friday. The company’s fifty day moving average is $487.98 and its two-hundred day moving average is $442.67. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The company has a market capitalization of $182.10 billion, a P/E ratio of 82.20, a PEG ratio of 5.11 and a beta of 1.39.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James raised their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Finally, BTIG Research set a $535.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,458,979.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 52,192 shares of company stock valued at $25,398,571 over the last quarter. 0.90% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.